Clinical trial
Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small…
NCT00329472 · Samsung Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00329472 |
|---|---|
| Title | Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer |
| Official title | Randomized Phase III Trial of Neoadjuvant Chemotherapy Followed by Surgery Plus Adjuvant Chemotherapy Versus Surgery Plus Adjuvant Chemotherapy in Stage IB, IIA, IIB and T3N1 Non-small Cell Lung Cancer (ICON) |
| Lead sponsor | Samsung Medical Center, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | gemcitabine, cisplatin |
| Enrollment | 0 |
| Start date | Apr 1, 2006 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | May 24, 2006 |
| Last update posted | Aug 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: